1. Home
  2. GBIO vs PXLW Comparison

GBIO vs PXLW Comparison

Compare GBIO & PXLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • PXLW
  • Stock Information
  • Founded
  • GBIO 2016
  • PXLW 1997
  • Country
  • GBIO United States
  • PXLW United States
  • Employees
  • GBIO N/A
  • PXLW 196
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • PXLW Semiconductors
  • Sector
  • GBIO Health Care
  • PXLW Technology
  • Exchange
  • GBIO Nasdaq
  • PXLW Nasdaq
  • Market Cap
  • GBIO 29.2M
  • PXLW 28.1M
  • IPO Year
  • GBIO 2020
  • PXLW 2000
  • Fundamental
  • Price
  • GBIO $0.38
  • PXLW $9.58
  • Analyst Decision
  • GBIO Strong Buy
  • PXLW Strong Buy
  • Analyst Count
  • GBIO 4
  • PXLW 2
  • Target Price
  • GBIO $7.33
  • PXLW $15.00
  • AVG Volume (30 Days)
  • GBIO 558.2K
  • PXLW 80.4K
  • Earning Date
  • GBIO 08-06-2025
  • PXLW 08-06-2025
  • Dividend Yield
  • GBIO N/A
  • PXLW N/A
  • EPS Growth
  • GBIO N/A
  • PXLW N/A
  • EPS
  • GBIO N/A
  • PXLW N/A
  • Revenue
  • GBIO $24,556,000.00
  • PXLW $34,246,000.00
  • Revenue This Year
  • GBIO N/A
  • PXLW $5.21
  • Revenue Next Year
  • GBIO N/A
  • PXLW $35.68
  • P/E Ratio
  • GBIO N/A
  • PXLW N/A
  • Revenue Growth
  • GBIO 146.47
  • PXLW N/A
  • 52 Week Low
  • GBIO $0.32
  • PXLW $4.67
  • 52 Week High
  • GBIO $3.65
  • PXLW $14.16
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 48.07
  • PXLW 75.21
  • Support Level
  • GBIO $0.35
  • PXLW $4.67
  • Resistance Level
  • GBIO $0.41
  • PXLW $6.68
  • Average True Range (ATR)
  • GBIO 0.03
  • PXLW 0.78
  • MACD
  • GBIO -0.00
  • PXLW 0.32
  • Stochastic Oscillator
  • GBIO 30.11
  • PXLW 90.36

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About PXLW Pixelworks Inc.

Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.

Share on Social Networks: